-
Toxic Epidermal Necrolysis (TEN) is Usually Due to Adverse Drug Reaction
Patients with Toxic Epidermal Necrolysis (TEN) Often Have Fatal Outcome Toxic epidermal necrolysis (TEN) is an infrequent, yet often fatal, severe systemic and cutaneous disease that is most often the result of an adverse…
-
Drug-induced Rhabdomyolysis and Acute Renal Failure (ARF) Cases On Increase
Rhabdomyolysis is Result of Skeletal Muscle Injury Caused by Drugs (and Other Things) The number of drug-induced rhabdomyolysis adverse event reports submitted to the FDA is rising, seemingly due to the introduction to market…
-
Lilly Plans to Settle Most Zyprexa Legal Cases for $690 Million
Zyprexa Lawsuits Alleged Failure to Warn About Diabetes Side Effect Risk In the first part of June 2005, Eli Lilly & Co. said it had reached an agreement with certain groups of plaintiffs’ lawyers…
-
Pharmacists in Florida Must Warn Patients About Certain Drug Risks
Appellate Court Imposes New Legal Duty on Florida Pharmacists In early June 2005 a Florida appellate court ruled that a Florida pharmacist can be held legally liable for failing to warn patients about certain…
-
Tysabri: Will this Multiple Sclerosis Drug Return to U.S. Market or Not?
Fourth Case of Tysabri-related PML is Reported to FDA by Manufacturer A fourth patient taking the multiple sclerosis drug Tysabri may have contracted a deadly brain disease called progressive multifocal leukoencephalopathy, or PML, calling…
-
FDA Announces Recall of All Drugs from Able Laboratories
All Able Laboratories Drugs Recalled Due to Production Quality Concerns On June 1, 2005 the FDA announced that the agency has issued a nationwide recall of all drugs — mostly generic prescription drugs, including…
